Problems › Busy But Not Profitable › Healthcare Providers
Full capacity and thin profit is a pricing and selection problem wearing an operations costume. This page works through it for healthcare providers specifically — including an unedited excerpt from a real analysis of a healthcare provider.
Full capacity and thin profit is a pricing and selection problem wearing an operations costume. For healthcare providers, this shows up in a particular place. The numbers that carry the answer are cost per episode and payer mix, and the complication specific to this industry is that downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it. The general version of this problem and the one you are actually in have different first moves.
When a business is at capacity and still not making money, the instinct is to look for waste. Usually there is some, and removing it will not fix this, because the cause is upstream: the work being accepted is not priced for what it actually consumes.
The pattern is consistent. A few accounts or jobs earn well. A long tail earns nothing but keeps everyone occupied, so the business feels healthy and the bank balance disagrees. Because the tail absorbs the capacity, the profitable work cannot expand — the constraint is not demand, it is that the constraint is already full of the wrong work.
The fix is a selection rule, not a productivity programme. Once you can rank work by contribution, most of the decision makes itself.
Home-services operators — HVAC, plumbing, electrical, landscaping, cleaning — hit this as a full calendar and a thin bank account: emergency jobs displace quoted work, and nobody can say which job type pays for the truck. There is no home-services industry hub until a profile and a run exist; the bind is still this page, not a twelfth grid.
These three together are the signature. One on its own usually points somewhere else.
✓ Everyone is fully occupied and cash is tight
✓ You cannot say which jobs or accounts made money last year without a special analysis
✓ Turning work away feels impossible even when it is unprofitable
The move that usually makes it worse. Hiring to relieve the pressure, which expands capacity for unprofitable work and moves the problem one size larger.
It is for you if you run or finance a healthcare provider and everyone is fully occupied and cash is tight. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on a healthcare provider. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Cedar Ridge Health Partners, a sample company profile used for testing rather than a customer — 38,000 attributed lives under value-based contracts.
Excerpt from a real Percision run · Competitive Positioning · sample company profile
The move. Protect and grow the 34% operating-income ASC engine by replacing retiring surgeons and steering 212k attributed lives to the ASC within 24 months.
| Investment required | $3.0-4.0M total over 24 months ($1.8-2.2M surgeon succession + retention bonuses; $1.2-1.8M referral-optimization platform and analytics) |
| Expected return | Incremental $4.8-6.4M annual ASC contribution margin by Month 24; payback 14-18 months on $3.0-4.0M investment; lifts group operating margin from 4.2% to 5.8-6.4%. |
| Revenue, year 1 | $202-208M (ASC case volume +4-6%) |
| Revenue, year 2 | $212-220M (ASC case volume +6-8%; physician retention +2-3%) |
| Revenue, year 3 | $225-235M (ASC contribution ≥40% of operating income) |
| Exit criteria | Strategy abandoned if, by Month 12, fewer than two qualified orthopaedic surgeon candidates have signed LOIs OR if ASC case volume has not grown at least 2% YoY; in either case, board must decide within 30 days whether to pivot to hospital-system sale process at 8-10× EBITDA. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Proprietary EFF Methodology, one of 29 engagements the platform runs. For healthcare providers it works through cost per episode, payer mix, panel size and contribution per provider, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
Rank by contribution per unit of your real constraint — machine hour, billable hour, delivery slot, square foot. Not by revenue, and not by gross margin percentage, both of which reliably favour the wrong work when the constraint is capacity.
Sometimes, and it is usually cheaper than the alternative. In practice a price that reflects what the work consumes either makes the account profitable or moves it to a competitor, and both outcomes are better than the current one.
Test it: if every job ran perfectly with zero waste, would the thin ones make money? If the answer is no, it is pricing and selection, and no efficiency programme will reach it.
Materially, yes. Downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are cost per episode, payer mix, panel size, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on cost per episode and payer mix. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.